| 注册
首页|期刊导航|中国脑血管病杂志|颅内动脉瘤行血管内治疗的抗血小板聚集药物应用研究进展

颅内动脉瘤行血管内治疗的抗血小板聚集药物应用研究进展

王思敏 向思诗 张鸿祺

中国脑血管病杂志2025,Vol.22Issue(2):105-112,8.
中国脑血管病杂志2025,Vol.22Issue(2):105-112,8.DOI:10.3969/j.issn.1672-5921.2025.02.006

颅内动脉瘤行血管内治疗的抗血小板聚集药物应用研究进展

Research progress on application of antiplatelet drug in endovascular treatment of intracranial aneurysms

王思敏 1向思诗 1张鸿祺1

作者信息

  • 1. 100053 北京,首都医科大学宣武医院神经外科
  • 折叠

摘要

Abstract

Intracranial aneurysms are a common cerebrovascular disease and the leading cause of subarachnoid hemorrhage.With the development of endovascular interventional techniques,more and more patients are being treated with stents or flow diverter.For this reason,antiplatelet therapy has become a routinely administered drug before and after endovascular interventions.This review intends to summarize the common antiplatelet drug classes,drug mechanisms,platelet function tests and clinical applications.

关键词

颅内动脉瘤/血小板聚集抑制剂/血管内治疗/综述

Key words

Intracranial aneurysm/Platelet inhibitor/Endovascular treatment/Review

引用本文复制引用

王思敏,向思诗,张鸿祺..颅内动脉瘤行血管内治疗的抗血小板聚集药物应用研究进展[J].中国脑血管病杂志,2025,22(2):105-112,8.

基金项目

国家自然科学基金(62201366) (62201366)

中国脑血管病杂志

OA北大核心

1672-5921

访问量0
|
下载量0
段落导航相关论文